Amneal Pharmaceuticals, Inc.

AMRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001723128

SEC filings (opens in a new tab)

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of AMRX: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	154	1	168	+15
Shares	100.8M	3.00K	100.2M	−572.5K (−0.6%)
Value	$481.1M	$14.0K	$417.2M	−$63.8M (−13.3%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to AMRX in Q1 2022
Institution	Shares	Value	% of portfolio
AQR Capital Management LLC	236,998	$988.0K	0.00%
FMR LLC	124,253	$518.0K	0.00%
Graham Capital Management, L.P.	103,532	$431.0K	0.02%
APG Asset Management N.V.	114,700	$430.0K	0.00%
Renaissance Technologies LLC	68,600	$286.0K	0.00%
DuPont Capital Management Corp	44,756	$187.0K	0.01%
EMC Capital Management	40,417	$156.0K	0.11%
Highland Capital Management, LLC	29,250	$122.0K	0.01%
Virtu Financial LLC	26,099	$109.0K	0.01%
Belvedere Trading LLC	25,161	$106.0K	0.07%
MQS Management LLC	22,136	$92.0K	0.07%
Atria Wealth Solutions, Inc.	18,000	$75.0K	0.00%
Amalgamated Financial Corp.	16,235	$68.0K	0.00%
Mirabella Financial Services LLP	15,128	$63.0K	0.01%
Meeder Asset Management Inc	14,923	$62.0K	0.00%
Two Sigma Securities, LLC	14,392	$60.0K	0.01%
Running Point Capital Advisors, LLC	10,000	$42.0K	0.02%
First Quadrant L P	8,791	$37.0K	0.21%
TCWP LLC	693	$2.00K	0.00%
Geneos Wealth Management Inc.	200	$0	0.00%
Disciplined Investments, LLC	5	$0	0.00%
Cordant, Inc.	11	$0	0.00%
SJS Investment Consulting Inc.	1	$0	0.00%
Schubert & Co	1	$0	0.00%

Sold out (9)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of AMRX in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
HRT Financial LP	64,148	$307.0K
Susquehanna Fundamental Investments, LLC	42,100	$202.0K
XTX Topco Ltd	23,742	$114.0K
ExodusPoint Capital Management, LP	23,292	$112.0K
SG Americas Securities, LLC	15,547	$74.0K
Quantamental Technologies LLC	10,810	$52.0K
Smith Group Asset Management, LLC	4,190	$20.0K
Snowden Capital Advisors LLC	1,561	$7.00K
Fortitude Advisory Group L.L.C.	57	$0

Not filed for Q1 2022 yet (1)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AMRX in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
NEXT Financial Group, Inc	3,000	$14.0K